News
UBS upped FinVolution Group (NYSE:FINV)’s stock to Buy from Neutral, increasing the price target from $11.80 to $12.10. As ...
Redburn Atlantic turned bullish on Charles River Laboratories International, Inc. (NYSE:CRL) as it upgraded its stock from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback